The largest database of trusted experimental protocols

Maxisorp microtiter plate

Manufactured by Thermo Fisher Scientific
Sourced in Germany, Denmark, United States

Maxisorp microtiter plates are a laboratory product designed for various immunoassay applications. The plates feature a high-binding surface that helps optimize the adsorption of proteins, antibodies, and other biomolecules. They are commonly used in techniques such as enzyme-linked immunosorbent assay (ELISA) to facilitate the detection and quantification of target analytes.

Automatically generated - may contain errors

110 protocols using maxisorp microtiter plate

1

Sandwich ELISA Methodology for Protein Detection

Check if the same lab product or an alternative is used in the 5 most similar protocols
Sandwich ELISAs were performed as follows: The 96-well MaxiSorp microtiter plates (Nunc) were coated with capture antibodies overnight at 4 °C. The detection antibodies were labeled with biotin according to standard protocols [20 (link)]. After coating, plates were blocked for 1 h at room temperature with BSA-Block Solution (Candor Bioscience). Biotinylated detection antibody (R&D Systems) and sample or reference protein were diluted in assay buffer (Low Cross Buffer, Candor Bioscience), added to the plate, and incubated for 60 min at 37 °C. Streptavidin-horseradish-peroxidase (Jackson Immuno Inc.) was added, and samples were incubated for 30 min at 37 °C. After washing, TMB substrate (Enhanced K-Blue, Neogen) was added, and after 30 min at 37 °C, the reaction was stopped with 1 M HCl solution. Plates were washed using a Hydrospeed-Washer from TECAN. Sample readout was achieved at 450 nm with a TECAN F50 Infinite reader using Magellan 7.0 software.
+ Open protocol
+ Expand
2

Quantifying Soluble IL-6 Receptor Levels

Check if the same lab product or an alternative is used in the 5 most similar protocols
Circulating sIL-6R concentrations were measured in BABYDIET and BABYDIAB serum samples using a highly sensitive non-isotopic time-resolved fluorescence ELISA assay based on the dissociation-enhanced lanthanide fluorescent immunoassay technology (DELFIA; PerkinElmer), as described45 (link). Test samples were diluted 1:20 in PBS+10% FBS and measured in duplicate on 384-well MaxiSorp microtiter plates (Nunc), coated with 1 μg ml−1 monoclonal anti-human IL-6R antibody (clone 17506; RD Systems). Detection was performed using a biotinylated mouse anti-CD126 monoclonal antibody (clone M182, BD Biosciences) diluted to a final concentration of 100 ng ml−1 in PBS+10% FBS and a Europium-Streptavidin detection solution (PerkinElmer), diluted in PBS+0.05% tween, 1% BSA, 7 μg ml−1 DTPA to a final concentration of 0.05 μg ml−1. Quantification of test samples was obtained by fitting the readings to a human recombinant IL-6Rα (RD systems) serial dilution standard curve plated in quadruplicate on each plate. Data for 782 unique individuals existed from 722 families.
+ Open protocol
+ Expand
3

Evaluating NANOBODY Binding Specificity

Check if the same lab product or an alternative is used in the 5 most similar protocols

Example 40

In order to determine binding specificity to H5, the different multivalent NANOBODIES® (VHH sequences) were tested in an ELISA binding assay in different concentrations. In short, 2 μg/ml of H5 were immobilized directly on Maxisorp microtiter plates (Nunc). Free binding sites were blocked using 4% Marvel in PBS. Next, Dilutions (1/10) of the NANOBODIES® (VHH sequences) starting with 10 pM in 100 μl 2% Marvel PBST were allowed to bind to the immobilized antigen. After incubation and a wash step, NANOBODY® (VHH sequence) binding was revealed using a rabbit-anti-VHH secondary antibody (a VHH). After a wash step the NANOBODIES® (VHH sequences) were detected with a HRP-conjugated goat-anti-rabbit antibody (GARPO). Binding specificity was determined based on OD values compared to controls (192-C4; SEQ ID NO: 163) against HRSV and 213-H7-15GS-213-H7 (SEQ ID NO: 2427) against Rabies). The multivalent NANOBODIES® (VHH sequences) show higher binding capacity than the monovalent (FIG. 34).

+ Open protocol
+ Expand
4

Screening Hybridoma Supernatants for Anti-DBLβ3_D4 Antibodies

Check if the same lab product or an alternative is used in the 5 most similar protocols
Hybridoma cell supernatants were screened for PFD1235w DBLβ3_D4-reactive Abs using ELISA. Duplicate wells of MaxiSorp microtiter plates (Nunc) were coated with DBLβ3_D4 (50 μl; 1 μg/ml; 0.1 M glycine/HCl buffer pH 2.75; overnight; 4°C) and blocked with blocking buffer (PBS, 0.5 M NaCl, 1% Triton X-100, 1% BSA, pH 7.2). A total of 100 μl undiluted cell supernatant was added (1 h; room temperature). The plates were washed in PBS + 1% Triton X-100, and bound Ab was detected with an anti-mouse Ig-HRP (Dako; 1:3000 in blocking buffer). After 1 h of incubation, plates were developed using OPD tablets (Dako) according to the manufacturer’s instructions. The OD value was read at 490 nm using a VERSAmax microplate reader (Molecular Devices) and Softmax Pro v4.7.1.
+ Open protocol
+ Expand
5

Serum IgG Quantification by ELISA

Check if the same lab product or an alternative is used in the 5 most similar protocols
Serum H56-specific IgG were determined by ELISA. Flat bottomed Maxisorp microtiter plates (Nunc, Denmark) were coated with H56 (0.5 µg/ml) for 3 h at 37°C and overnight at 4°C in a volume of 100 µl/well. Plates were washed and blocked with 200 µl/well of PBS containing 1% BSA (Sigma-Aldrich) for 2 h at 37°C. Serum samples were added and titrated in twofold dilution in duplicate in PBS supplemented with 0.05% Tween 20 and 0.1% BSA (diluent buffer) in 100 µl/well. After 2 h at 37°C, samples were incubated with the alkaline phosphatase-conjugate goat anti-mouse IgG (diluted 1:1,000 in diluent buffer, Southern Biotechnology, USA) for 2 h at 37°C in 100 µl/well and developed by adding 1 mg/ml of alkaline phosphatase substrate (Sigma-Aldrich) in 200 µl/well. The optical density was recorded using Multiskan FC Microplate Photometer (Thermo Scientific). Antibody titers were expressed as the reciprocal of the highest serum dilution with an OD value ≥0.2, after subtraction of background values measured with diluent buffer alone.
+ Open protocol
+ Expand
6

Glycan-Galectin Binding Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
The synthesized glycans and neo-glycoproteins were analyzed for binding of Gal-3 and Gal-1 in 96-well microtiter plate formats [37 (link),41 (link)]. Glycans 11 and 12, as well as the corresponding LacNAc-LacNAc-linker-NH21a and LacdiNAc-LacNAc-linker-NH22a (deprotected forms of 1 and 2) were immobilized via the amino group in aminoreactive microtiter plates (Immobilizer Amino, Nunc, Wiesbaden, Germany). The immobilization of 5 nmol glycan in sodium carbonate buffer (100 mM, pH 9.6) was done overnight. For immobilizing neo-glycoproteins, 5 pmol protein were incubated in PBS (pH 7.5) in MaxiSorp microtiter plates (Nunc) overnight. Wells were then washed with PBS-Tween (0.05% (v/v)) and blocked with 2% BSA in PBS followed by incubation for one hour with galectins diluted in EPBS. Incubation with anti-His6-peroxidase (Roche) was done subsequently. Microtiter plates were read out at 495 nm after conversion of OPD substrate (o-phenylenediamine, Dako, Hamburg, Germany). Measured data were analyzed using Sigma Plot (Systat software GmbH, Erkrath, Germany).
+ Open protocol
+ Expand
7

ELISA for Detection of pE6 Antibodies

Check if the same lab product or an alternative is used in the 5 most similar protocols
The ELISA was essentially performed as described previously [51 (link)], using either the purified native pE6 protein or the CaSki cells as the plate-bound antigen. Briefly, 96-well maxisorp microtiter plates (Nunc, Naperville, IL, USA) were coated with pE6 (300 ng/well) in PBS or with CaSki lysates (105 cells/well) in 0.05 M carbonate–bicarbonate buffer, pH 9.6, and incubated overnight at 4°C. CaSki cells were disrupted by freeze-thawing three times and MRC-5 cells were used as a negative control. The sera were then added at a 1:50 dilution, and the binding was revealed by a 1:2000 dilution of goat anti-mouse HRP-conjugated sera (Dako) and tetramethylbenzidine substrate (Sigma-Aldrich Italia, Milan, Italy). The absorbance for each well was measured at 450 nm with a 550 microplate reader (Bio-Rad Laboratories, Hercules, CA, USA).
+ Open protocol
+ Expand
8

ELISA and Immunoblot Analysis of AnAPN1

Check if the same lab product or an alternative is used in the 5 most similar protocols
For ELISAs, 96-well Maxisorp microtiter plates (Nunc, Fisher Scientific) were coated with the NT135aaAnAPN1 or An. gambiae midgut lysate as previously described8 (link). The optical density (O.D. 450 nm) and reciprocal serum dilutions were measured on a Molecular Devices absorbance microplate reader. End point titers were defined as the highest reciprocal serum dilution giving an O.D. reading greater than that of pre-immune serum plus 3 standard deviations. For immunoblots, NT135aaAnAPN1 or the near full-length S2-expressed AnAPN1 were resolved on a 4-20% Tris-Glycine SDS-PAGE gel and transferred to nitrocellulose membrane. The blot was incubated with 4H5B7 mAb (30 μg/mL) overnight at 4°C and then detected with goat anti-mouse IgG 680LT Ab (1:50,000) for 1 hour at room temp using the Li-Cor Odyssey Near-infrared imager (Li-Cor). Peptide epitope-mapping ELISAs were performed as described8 (link).
+ Open protocol
+ Expand
9

Quantification of Gluten Content

Check if the same lab product or an alternative is used in the 5 most similar protocols
Gluten proteins were extracted according to the manufacturer’s instructions using Universal Gluten Extraction Solution UGES (Biomedal SL, Seville, Spain). Maxisorp microtiter plates (Nunc, Roskilde, Denmark) were coated with Prolamin Working Group (PWG) gliadin solution and incubated overnight at 4°C. The plates were washed with PBS-Tween 20 buffer and blocked with blocking solution (phosphate-buffered saline (PBS)-5% non-fat dry milk) for 1 h at RT. Different dilutions of each sample as well as standard solution of PWG gliadin were made in PBS-bovine serum albumin 3%, to each of which was added horseradish peroxidase–conjugated G12 mAb solution. The samples were pre-incubated at RT and added to the wells. After 30 min of incubation at RT, the plates were washed, and 3,3′,5,5′-tetramethylbenzidine (TMB) substrate solution (Sigma, St. Louis, Missouri, USA) was added. After 30 min of incubation at RT in the dark, the reaction was stopped with 1 M sulfuric acid, and the absorbance at 450 nm was measured (microplate reader UVM340, Asys Hitech GmbH, Eugendorf, Austria). Results were expressed in parts per million (ppm) in dry matter for the flour, and in a 35% humidity basis for the bread loaves. In order to estimate the total gluten content the results obtained were multiplied by two. Data were obtained from three independent experiments with samples run in triplicate.
+ Open protocol
+ Expand
10

B7-H1 Nanobody Competition Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols

EXAMPLE 22

In order to determine competition efficiency of B7-H1 binding Nanobodies, the positive clones of the previous binding assay were tested in an ELISA competition assay setup.

In short, 2 μg/ml B7-H1 ectodomain (rhB7H1-Fc, R&D Systems, Minneapolis, US, Cat #156-B7) was immobilized on maxisorp microtiter plates (Nunc, Wiesbaden, Germany) and free binding sites were blocked using 4% Marvel in PBS. Next, 0.5 μg/ml of PD-1 was preincubated with a dilution series of purified Nanobody. An irrelevant Nanobody against FcgR1 (49C5) was used as a negative controle, since this Nanobody does not bind to B7-H1. Unlabelled PD-1 was used as a positive controle for competition of PD1-biotin. The results are shown in FIG. 13. 3 Nanobody families show competition with PD-1-biotin for binding to B7-H1 in a dose-dependent manner.

+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!